Literature DB >> 12227946

Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature.

Josep Antoni Bombí1, Antonio Martínez, José Ramírez, Juan José Grau, Alfons Nadal, Pedro Luis Fernández, Antonio Palacín, Antonio Cardesa.   

Abstract

The authors reviewed a series of 110 surgical specimens of primary non-small cell lung carcinomas from the Department of Pathology at the Hospital Clinic, University of Barcelona Medical School, between 1987 and 1997. The sample included 25 squamous cell carcinomas, 60 adenocarcinomas, 14 large cell carcinomas, and 11 neuroendocrine tumors. Electron microscopic subcellular characteristics of the lung cancer cells were studied to define the squamous, adenoid, or neuroendocrine differentiation in each tumor. An immunohistochemical study for Cyclin D1 was performed in 96 cases. In 71 cases (65%) the author found a single ultrastructural differentiation, and in 30 cases (27%) ultrastructural differentiation was double: 25 adenosquamous and 5 adeno-neuroendocrine. In 3 cases a triple adeno-squamous-neuroendocrine differentiation was found. There were no cases of squamous-neuroendocrine differentiation. In 6 cases no differentiation of any kind could be found. Cyclin D1 overexpression was found in 58% of all tumors. The positive expression rates in squamous cell carcinoma and adenocarcinoma were 72% and 62%, respectively. In purely adenoid-differentiated tumors there was a strong association between high Cyclin D1 overexpression and differentiation (p=.006). In bronchioloalveolar carcinoma the positivity rate was 70%; all were heavy expressers, compared with 25% of heavy expressers in adenocarcinomas as a whole (p<.005). In purely squamous tumors differentiated ultrastructurally no relationship was found between high Cyclin D1 expression and degree of differentiation (p=.08). Lung cancers are morphologically and molecularly heterogeneous, and certain molecular alterations are related to specific subcellular characteristics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227946     DOI: 10.1080/01913120290076892

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  5 in total

Review 1.  [Neuroendocrine tumors of the lung].

Authors:  K-M Müller
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

2.  Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study.

Authors:  Kam-Meng Tchou-Wong; Sandra Y Y Fok; Jeffrey S Rubin; Fiona Pixley; John Condeelis; Filip Braet; William Rom; Lilian L Soon
Journal:  BMC Cancer       Date:  2006-06-07       Impact factor: 4.430

3.  The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.

Authors:  Saroj K Basak; Mysore S Veena; Scott Oh; Ge Huang; Eri Srivatsan; Min Huang; Sherven Sharma; Raj K Batra
Journal:  PLoS One       Date:  2009-06-12       Impact factor: 3.240

4.  Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer.

Authors:  Pengbo Deng; Chengping Hu; Lihua Zhou; Yuanyuan Li; Li Huang
Journal:  Mol Clin Oncol       Date:  2013-06-14

5.  Proteomic and ultrastructural analysis of Clara cell and type II alveolar epithelial cell-type lung cancer cells.

Authors:  Wen-Li Hou; Ming Chang; Xiao-Feng Liu; Lin-Sen Hu; Shu-Cheng Hua
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.